Genus logo

GNS - Genus Share Price

5035p 85.0  1.7%

Last Trade - 26/02/21

Large Cap
Market Cap £3.29bn
Enterprise Value £3.39bn
Revenue £551.4m
Position in Universe 229th / 1807
Unlock GNS Revenue
Relative Strength (%)
1m +3.82%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -8.70%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Jun 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
398.5 388.3 459.1 470.3 488.5 551.4 575.9 626.7 +6.7%
-15.0 +26.0 +7.9 -9.8 -3.1 +41.9 +41.5 +7.02
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 30 June 2020, Genus plcrevenues increased 13% to £551.4M. Net income increasedfrom £7.8M to £40.5M. Revenues reflect Operating Genus PICsegment increase of 18% to £298.8M, Operating Genus ABSsegment increase of 7% to £237.6M, Operating PorcineProduct Development segment increase of 24% to £11.7M, Asiasegment increase of 60% to £70.8M, North America segmentincrease of 7% to £226.4M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for GNS
Graphical History


GNS Revenue Unlock GNS Revenue

Net Income

GNS Net Income Unlock GNS Revenue

Normalised EPS

GNS Normalised EPS Unlock GNS Revenue

PE Ratio Range

GNS PE Ratio Range Unlock GNS Revenue

Dividend Yield Range

GNS Dividend Yield Range Unlock GNS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
GNS EPS Forecasts Unlock GNS Revenue
Profile Summary

Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company's segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe. The Genus ABS segment is engaged in bovine sales business, excluding Asia, and serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment is engaged in porcine and bovine business in Asia, and serves porcine, dairy and beef customers in Asian markets. In the porcine market, it sells boars and sows. In the dairy and beef markets, its primary product is bull semen. The Company offers embryos through its subsidiary, In Vitro Brasil S.A. Its porcine business has a network of over 600 breeding herds in approximately 40 countries.

Last Annual June 30th, 2020
Last Interim June 30th, 2020
Incorporated September 26, 1994
Public Since July 6, 2000
No. of Shareholders: n/a
No. of Employees: 2,969
GNS Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for GNS
Upcoming Events for GNS
Frequently Asked Questions for Genus
What is the Genus share price?

As of 26/02/21, shares in Genus are trading at 5035p, giving the company a market capitalisation of £3.29bn. This share price information is delayed by 15 minutes.

How has the Genus share price performed this year?

Shares in Genus are currently trading at 5035p and the price has moved by 59.44% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Genus price has moved by 54.59% over the past year.

What are the analyst and broker recommendations for Genus?

Of the analysts with advisory recommendations for Genus, there are there are currently 5 "buy" , 2 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Genus is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Genus next release its financial results?

Genus is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Genus dividend yield?

The Genus dividend yield is 0.58% based on the trailing twelve month period.

Does Genus pay a dividend?

Last year, Genus paid a total dividend of 0.29, and it currently has a trailing dividend yield of 0.58%. Looking ahead, shares in Genus are due to go ex-dividend on 2021-03-04 and the next dividend pay date is 2021-04-01.

When does Genus next pay dividends?

Genus are due to go ex-dividend on 2021-03-04 and the next dividend pay date is 2021-04-01. The historic dividend yield on Genus shares is currently 0.58%.

How do I buy Genus shares?

To buy shares in Genus you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Genus?

Shares in Genus are currently trading at 5035p, giving the company a market capitalisation of £3.29bn.

Where are Genus shares listed? Where are Genus shares listed?

Here are the trading details for Genus:

Country of listing: United Kingdom
Exchange: LSE
Ticker Symbol: GNS
What kind of share is Genus?

Based on an overall assessment of its quality, value and momentum, Genus is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Genus share price forecast 2021?

Shares in Genus are currently priced at 5035p. At that level they are trading at 0.08% premium to the analyst consensus target price of 5,030.98.

Analysts covering Genus currently have a consensus Earnings Per Share (EPS) forecast of 1.02195 for the next financial year.

How can I tell whether the Genus share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Genus. Over the past six months, the relative strength of its shares against the market has been 29.77%. At the current price of 5035p, shares in Genus are trading at 26.47% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Genus PE Ratio?

The Genus PE ratio based on its reported earnings over the past 12 months is 69.72. The shares are currently trading at 5035p.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Genus?

Genus's management team is headed by:

Bill Christianson - OTH
Jerry Thompson - OTH
Stephen Wilson - CEO
Dan Hartley - GCN
Lykele Van der Broek - NID
Lysanne Gray - NID
Nate Zwald - OTH
Angelle Rosata - DHR
Lesley Knox - NID
Ian Charles - NID
Elena Rice - CSO
Alison Henriksen - CFO
Iain Ferguson - NEC
Who are the major shareholders of Genus?

Here are the top five shareholders of Genus based on the size of their shareholding:

Baillie Gifford & Co. Investment Advisor
Percentage owned: 8.28% (5.41m shares)
Aberdeen Standard Investments (Edinburgh) Investment Advisor
Percentage owned: 7.18% (4.69m shares)
Columbia Threadneedle Investments (UK) Investment Advisor/Hedge Fund
Percentage owned: 5.15% (3.36m shares)
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund
Percentage owned: 4.52% (2.95m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 4.01% (2.62m shares)
Similar to GNS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.